Gelteq (NASDAQ:GELS) Issues Quarterly Earnings Results

Gelteq (NASDAQ:GELS) released its quarterly earnings results on Tuesday. The company reported ($0.12) earnings per share (EPS) for the quarter, FiscalAI reports.

Gelteq Trading Up 4.9%

NASDAQ GELS opened at $0.67 on Wednesday. Gelteq has a 1 year low of $0.39 and a 1 year high of $2.02. The company has a fifty day moving average price of $0.63 and a 200-day moving average price of $0.76.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Gelteq stock. Susquehanna International Group LLP acquired a new position in Gelteq Limited (NASDAQ:GELS) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq as of its most recent filing with the Securities and Exchange Commission.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Gelteq from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Gelteq has an average rating of “Sell”.

About Gelteq

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.